Tissue Banking Market Size, Share, Opportunities, And Trends By Tissue Type (Cornea, Skin, Bones, Heart Valves, Blood, Soft Tissues, Umbilical Cord), By Application (Therapeutic, Research and development, Others), And By Geography – Forecast From 2025 To 2030

Tissue Banking Market Size:

The global tissue banking market is expected to grow from USD 2.128 billion in 2025 to USD 3.286 billion in 2030, at a CAGR of 9.07%.

Tissue Banking Market Trends:

A tissue bank is considered a certain type of bank that collects fresh specimens and tissue for future needs. The tissue bank is considered one of the leading specimen or tissue storage systems in the world. The medical field and research and development sectors are presently widely seeking the application and help of tissue banks. The need for fresh specimens and tissues in the research and development sector is giving potential to the growth of the global tissue bank market.

The market players’ investment in the development and research in the cell and tissue regeneration field is also driving the growth of the global tissue bank market. The medical sector and hospitals are also widely seeking the support and assistance of tissue banks for the treatment of certain chronic disorders. Hospitals and health research institutions relying on tissue banks are boosting the market growth of global tissue banks.

The rising cases of chronic diseases like cancer, etc., and their treatment based on tissue regeneration are also boosting the market value of tissue banks in the global market. The support offered by governments and government organizations is also contributing to the growth of the global tissue banking market.

Tissue Banking Market Growth Drivers:

• The demand for  tissues for the treatment of chronic diseases

The rising demand for tissues for treating chronic diseases is increasing the market value of the global tissue banking sector. A tissue bank is a collection of various specimens and fresh tissues and is a relatively new discovery in the medical field that employs tissue for the treatment of chronic diseases, and is boosting the growth of the global tissue banking system. According to the American Association of Tissue Banks, the tissue banking network in the United States is exhibiting steady growth, with approximately 58 accredited tissue banks working in the United States alone.

The tissue banks working in the United States are also properly certified and accredited by the FDA (Food and Drug Administration) of the United States. The government of the U.S. has been encouraging the use of tissue banks. According to the report of AATB (American Association of Tissue Banks), blood tissues or blood cells account for the major share of the global tissue banking market. The need for fresh specimens and tissue in the treatment of chronic disorders and the regeneration of tissue cells is driving the growth of the global tissue banking market.

• Rising research and development

The growing trend of research and developments in tissue regeneration and the use of tissue in efficiently treating chronic diseases is boosting the growth of the global tissue banking market.  Discoveries of stem cells in developing any other tissue are one of the latest innovations in the medical and health research sector. The discoveries, like stem cells and others, are fuelling the market growth of tissue banking in the global market. The investment of major players like Allergan and Hamilton  Companies is boosting the applications and developments in tissue engineering. The wide research and development in tissue engineering and employing tissue for treating chronic diseases are contributing to the market growth.

Tissue Banking Market Geographical Outlook:

• North America has the largest market share 

Geographically, the North American region has the largest share of the global tissue banking market. The presence of a large number of tissue banks and increasing research and development in the tissue engineering sector are leading to growth in the North American region in the tissue banking market. The presence of major market players and the rising number of chronic diseases are also driving the market growth in the North American tissue banking market.

Tissue Banking Market Segmentation

• By Tissue Type
  • Cornea
  • Skin
  • Bones
  • Heart Valves
  • Others
• By Storage Type
  • Cryopreservation
  • Deep-Freezing
  • Others
• By Application
  • Therapeutic
  • Research & Development
  • Tissue Engineering
  • Others
• By End-User
  • Hospitals
  • Research & Academic Institutes
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. TISSUE BANKING MARKET BY TISSUE TYPE

5.1. Introduction

5.2. Cornea

5.3. Skin

5.4. Bones

5.5. Heart Valves

5.6. Others

6. TISSUE BANKING MARKET BY STORAGE TYPE

6.1. Introduction

6.2. Cryopreservation

6.3. Deep-Freezing

6.4. Others

7. TISSUE BANKING MARKET BY APPLICATION

7.1. Introduction

7.2. Therapeutic

7.3. Research & Development

7.4. Tissue Engineering

7.5. Others

8. TISSUE BANKING MARKET BY END-USER

8.1. Introduction

8.2. Hospitals

8.3. Research & Academic Institutes

8.4. Others

9. TISSUE BANKING MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Life Link Tissue Bank

11.2. Alamo Biologics

11.3. ViaCord (Revvity Inc.)

11.4. DCI Donor Services Tissue Bank

11.5. Thermo Fisher Scientific Inc.

11.6. Azenta Life Sciences

11.7. Tecan Group Ltd.

11.8. BioLife Solutions, Inc.

11.9. PHC Corporation

11.10. Rokit Healthcare

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Life Link Tissue Bank

Alamo Biologics

ViaCord (Revvity Inc.)

DCI Donor Services Tissue Bank

Thermo Fisher Scientific Inc.

Azenta Life Sciences

Tecan Group Ltd.

BioLife Solutions, Inc.

PHC Corporation

Rokit Healthcare